Lantern PharmaLTRN
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 33 institutions reported holding Lantern Pharma Inc. (LTRN) in their 13F filings, up 3 from Q3 2025. 6 opened new positions and 3 sold out. The largest holders were BIOS Capital Management, LP ($3.1M), Vanguard Group Inc. ($1.2M) and CM Management, LLC ($682K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lantern Pharma Inc.
- CUSIP
- 51654W101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $239K |
| Exits | 3 | $158K |
All 13F filers, Q3 2025 → Q4 2025: 95,973 shares bought and 90,016 shares sold, net +5,957 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| BIOS Capital Management, LP | 3.70% | Reduce -0.6% | 1,009,507 | $3.1M |
| Vanguard Group Inc. | 0.00% | No change | 384,041 | $1.2M |
| CM Management, LLC | 0.57% | No change | 225,000 | $682K |
| Renaissance Technologies | 0.00% | Add +10.3% | 110,400 | $335K |
| Geode Capital Management, LLC | 0.00% | Add +5.1% | 96,742 | $293K |
| Voss Capital, LP | 0.01% | No change | 50,000 | $152K |
| BlackRock, Inc. | 0.00% | Add +2.7% | 44,253 | $134K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -2.6% | 39,110 | $119K |
| NewEdge Advisors, LLC | 0.00% | Reduce -19.5% | 38,069 | $115K |
| Westside Investment Management, Inc. | 0.02% | No change | 35,900 | $109K |
| Citadel Advisors | 0.00% | New | 32,895 | $100K |
| Susquehanna International Group, LLP | 0.00% | Reduce -26.3% | 28,820 | $87K |
| Horizon Kinetics Asset Management LLC | 0.00% | Reduce -4.2% | 27,582 | $84K |
| Bank of New York Mellon Corp | 0.00% | No change | 26,481 | $80K |
| DAVENPORT & Co LLC | 0.00% | Reduce -7.8% | 23,814 | $72K |
| State Street Corp. | 0.00% | No change | 23,652 | $72K |
| Focus Partners Wealth | 0.00% | New | 15,982 | $48K |
| Northern Trust Corp. | 0.00% | No change | 15,589 | $47K |
| CIBC Private Wealth Group LLC | 0.00% | New | 15,432 | $47K |
| Cetera Investment Advisers | 0.00% | New | 12,228 | $37K |
| UBS Group AG | 0.00% | Reduce -68.0% | 10,627 | $32K |
| Group One Trading LLC | 0.00% | Reduce -19.7% | 4,072 | $12K |
| Simplex Trading, LLC | 0.00% | Add +58.3% | 2,257 | $7K |
| Curio Wealth, LLC | 0.00% | New | 2,000 | $7K |
| SBI Securities Co., Ltd. | 0.00% | No change | 2,143 | $6K |
| Wells Fargo & Company | 0.00% | Reduce -14.5% | 1,475 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +95.6% | 841 | $3K |
| Morgan Stanley | 0.00% | No change | 601 | $2K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 500 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 215 | $651 |
| JPMorgan Chase & Co. | 0.00% | New | 69 | $209 |
| Bank of America Corp. | 0.00% | Add +16.7% | 7 | $21 |
| Key Financial Inc | 0.00% | No change | 2 | $6 |
"% of holder's portfolio" is LTRN's weight in each manager's 13F, not the share of Lantern Pharma Inc. the manager owns.